As health systems across the Middle East and Africa confront the dual pressures of rising non-communicable diseases (NCDs) and persistent access gaps, AstraZeneca is placing health equity at the heart ...
Pharma companies are seeing the value of digital health, and are creating departments focused on developing, scaling and investing in platforms that use technology to enhance life sciences R&D, better ...
AstraZeneca PLC (LON:AZN), a leading global biopharmaceutical company with a market capitalization of $216.74 billion, has been making significant strides in the pharmaceutical industry, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results